Rifat Pamukcu

Rifat Pamukcu, MD, is a distinguished member of the Biolocity Fund Oversight Committee.13 He brings extensive experience in therapeutics commercialization, with over 28 years in the field.2 Dr. Pamukcu currently serves as the President and CEO of Midway Pharmaceuticals Inc.1

In addition to his role at Biolocity, Dr. Pamukcu holds several other notable positions:

1. Director at Syantra
2. Member of the Oversight Committee for the Coulter-Drexel Translational Partners Fund
3. Former Assistant Professor at the University of Pennsylvania School of Medicine5

Dr. Pamukcu's expertise in biotechnology and medical technology commercialization makes him a valuable asset to the Biolocity Oversight Committee. The committee serves as both an advisory council and a decision-making board for selecting funded projects, comprising clinical, industry, regulatory, investment, and entrepreneurial veterans with relevant technology and medical expertise.1

Given his extensive background in therapeutics and his leadership roles in the pharmaceutical industry, Dr. Pamukcu likely contributes significant insights to Biolocity's mission of supporting university medical technology commercialization in the southeast.4